To overcome this challenge, it will take farmers like me. We can’t fight in the court of law, but we can make our voices heard in the court of public opinion.
Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.
Mangaluru: A feasibility study by the Karnataka Digital Economy Mission (KDEM) to assess whether the city can be designated ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Why does it matter to pharma companies? How Syneos Health Communications can help; Whether you work in healthcare communications, pharmaceutical marketing or biotech ...
IS THE PRINCIPAL INVESTIGATOR IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a biotech/life ...
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
Replimune stock doubled to $9.00 after FDA accepted its resubmitted application for melanoma drug RP1, with decision expected April 2026.
After Omeros decided to hit pause on developing its MASP-3 inhibitor zaltenibart, Novo Nordisk has spied an opportunity to scoop up the rare disease drug. Omeros spent the first weeks of the year ...
A California scientist and former magician who claimed he had discovered the cure for HIV has been found guilty of orchestrating the murder of a business rival who was found dead in a Vermont snowbank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback